ProfileGDS4132 / 217872_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 86% 90% 91% 89% 90% 90% 88% 89% 89% 90% 89% 90% 91% 90% 88% 86% 90% 92% 92% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101331.81186
GSM201543Muscle PCOS pioglitazone 121401.70590
GSM201544Muscle PCOS pioglitazone 161497.56591
GSM201545Muscle PCOS pioglitazone 201446.45389
GSM201829Muscle PCOS pioglitazone 231453.88490
GSM201830Muscle PCOS pioglitazon 251429.51590
GSM201831Muscle PCOS pioglitazone 271394.63388
GSM201832Muscle PCOS pioglitazone 31405.12789
GSM201833Muscle PCOS pioglitazone 41398.47589
GSM201834Muscle PCOS pioglitazone 81464.76690
GSM201835Muscle PCOS after pioglitazone 102434.03189
GSM201836Muscle PCOS after pioglitazone 122468.90190
GSM201837Muscle PCOS after pioglitazone 162490.04391
GSM201838Muscle PCOS after pioglitazone 202491.14690
GSM201839Muscle PCOS after pioglitazone 232407.52988
GSM201840Muscle PCOS after pioglitazone 252382.56186
GSM201841Muscle PCOS after pioglitazone 272461.12390
GSM201842Muscle PCOS after pioglitazone 32539.65192
GSM201843Muscle PCOS after pioglitazone 42555.33392
GSM201844Muscle PCOS after pioglitazone 82514.50591